Gene Therapy
Scientists at University of Cologne target Gene Therapy
Published in Gene Therapy Weekly, September 13th, 2007
In this recent report published in the journal Molecular Imaging, researchers in Cologne, Germany conducted a study "To develop efficient and safe gene therapy approaches, the herpes simplex virus type 1 thymidine kinase gene (HSV-1-tk) has been shown to function as a marker gene for the direct noninvasive in vivo localization of thymidine kinase (TK) expression by positron emission tomography (PET) using radiolabeled nucleoside analogues as specific TK substrates. Moreover, the gene encoding dopamine type 2 receptor (d2r) could be used as a PET marker gene using specific radiolabeled receptor binding compounds."
"Here we describe the quantitative colocalization...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2007-09-13)
More Articles from Gene Therapy Weekly
- Biomedicine
Binghamton University researchers investigate evolving malaria resistance - Gene Therapy
Gamma globulin effective in treating eye infections caused by adenoviruses - Gene Therapy
One Species’ Genome Discovered Inside Another’s - Leukemia
Novel MS drug shows promise in two lethal leukemias - Malaria
Advance in Effort to Fight Malaria by Tricking the Mosquito’s Sense of Smell - Biotherapy
Renal Solutions Announces Collaborative Agreement with Innovative BioTherapies - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
